publication venue for
- The profile of the causative organisms which lead to septic arthritis of native joints over the last two decades in a single tertiary medical center in the east coast of the United States.. 75. 2021
- Time trends in use of the CHADS2 and CHA2 DS2 VASc scores, and the geographical and specialty uptake of these scores from a popular online clinical decision tool and medical reference.. 73. 2018
- Relationship between age and erectile dysfunction diagnosis or treatment using real-world observational data in the USA.. 70. 2016
- Impact of cardiovascular risk factors and related comorbid conditions and medical therapy reported at baseline on the treatment response to tadalafil 5 mg once-daily in men with lower urinary tract symptoms associated with benign prostatic hyperplasia: an integrated analysis of four randomised, double-blind, placebo-controlled, clinical trials.. 69. 2015
- The prognostic implications of lack of palpitations in patients hospitalised with atrial fibrillation: observations from a 20-year registry.. 68. 2014
- A 5-year retrospective analysis of 5α-reductase inhibitors in men with benign prostatic hyperplasia: finasteride has comparable urinary symptom efficacy and prostate volume reduction, but less sexual side effects and breast complications than dutasteride.. 66. 2012
- Bleeding risk with AZD6140, a reversible P2Y12 receptor antagonist, vs. clopidogrel in patients undergoing coronary artery bypass grafting in the DISPERSE2 trial.. 63. 2009
- Is daily mvi required in patients receiving parenteral nutrition?. 56. 2002
- Effect of doxazosin on the symptoms of benign prostatic hyperplasia: results from three double-blind placebo-controlled studies.. 51. 1997
- Are men shortchanged on health? Perspective on health care utilization and health risk behavior in men and women in the United States. 2010
- Fluoroquinolones in the management of community-acquired pneumonia. 2010
- Accelerated atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. 2005
- The potential value of erectile dysfunction inquiry and management. 2003
- High density lipoprotein: guardian of the vascular system? 2002
- The assessment of vascular risk in men with erectile dysfunction: the role of the cardiologist and general physician. 2013